Overview
Infective gastritis, particularly caused by Helicobacter pylori, involves inflammation of the gastric mucosa due to bacterial infection, distinct from other pathogens like Helicobacter mustelae. 1Diagnosis
Microbial Culture and Sensitivity: Essential for identifying H. pylori and differentiating from other helicobacters like H. mustelae. 1
Serology and Urea Breath Test: Useful for detecting H. pylori infection, though not specific for differentiating from other helicobacters.
Histology: Biopsy examination showing characteristic inflammatory changes and presence of bacteria.
Rapid Urease Test: Commonly used to detect H. pylori in gastric biopsies, but not applicable for other helicobacters.Management
First-Line Treatment: Triple therapy typically includes a proton pump inhibitor (PPI) plus clarithromycin and amoxicillin or metronidazole (doses vary by patient and local resistance patterns). [Evidence not directly provided in abstracts]
Adjunctive Treatments: Quadruple therapy (PPI, bismuth, metronidazole, tetracycline) may be used in areas with high resistance rates to clarithromycin and metronidazole. [Evidence not directly provided in abstracts]Special Populations
Pregnancy: Limited data; PPIs are generally considered safe but antibiotic choices should be carefully evaluated for teratogenic potential. [Evidence not directly provided in abstracts]
Pediatrics: Treatment regimens adjusted for weight and developmental stage; triple therapy adapted for pediatric dosing. [Evidence not directly provided in abstracts]
Elderly: Consideration of comorbidities and potential drug interactions; careful monitoring of renal and hepatic function. [Evidence not directly provided in abstracts]
Comorbidities: Presence of liver disease may necessitate dose adjustments of certain antibiotics; consult specific guidelines for tailored management. [Evidence not directly provided in abstracts]Key Recommendations
Differentiate Helicobacter pylori from other helicobacters like H. mustelae using protein profile analysis and toxin detection for accurate diagnosis. (Evidence: Expert opinion) 1
Employ triple therapy as first-line treatment for H. pylori gastritis, adjusting based on local antibiotic resistance patterns. (Evidence: Expert opinion)
Tailor treatment in special populations considering potential drug interactions and safety profiles, especially in pregnancy and elderly patients. (Evidence: Expert opinion)References
1 Morgan DR, Fox JG, Leunk RD. Comparison of isolates of Helicobacter pylori and Helicobacter mustelae. Journal of clinical microbiology 1991. link